Vicker Nigel, Su Xiangdong, Lawrence Harshani, Cruttenden Adrian, Purohit Atul, Reed Michael J, Potter Barry V L
Medicinal Chemistry, Department of Pharmacy and Pharmacology and Sterix Ltd, University of Bath, Bath BA2 7AY, UK.
Bioorg Med Chem Lett. 2004 Jun 21;14(12):3263-7. doi: 10.1016/j.bmcl.2004.03.107.
Using 18beta-glycyrrhetinic acid as a template, the synthesis of a series of secondary amides at the 30-position is described and the effects of these modifications on the SAR of the 11beta-hydroxysteroid dehydrogenase isozymes type 1 and 2 from the rat are investigated. An isoform selective inhibitor has been discovered and compound 5, N-(2-hydroxyethyl)-3beta-hydroxy-11-oxo-18beta-olean-12-en-30-oic acid amide, is highlighted as a very potent and selective inhibitor of 11beta-hydroxysteroid dehydrogenase 2 with an IC(50)=4 pM.
以18β-甘草次酸为模板,描述了在30位合成一系列仲酰胺的过程,并研究了这些修饰对大鼠1型和2型11β-羟基类固醇脱氢酶构效关系的影响。发现了一种同工型选择性抑制剂,化合物5,N-(2-羟乙基)-3β-羟基-11-氧代-18β-齐墩果-12-烯-30-酸酰胺,被突出显示为一种非常强效且选择性的11β-羟基类固醇脱氢酶2抑制剂,IC(50)=4 pM。